UroGen Pharma Ltd. Preferred Shares: Authorized and Outstanding
The company's filed XBRL preferred stock facts (us-gaap Preferred*), one row per period end, newest first. Values are as filed.
- 2017-12-31: Preferred Stock Dividends, Income Statement Impact $825.00K; Preferred Stock, Dividend Rate, Percentage 8.00%.
- 2017-09-30: Preferred Stock Dividends, Income Statement Impact $825.00K.
- 2017-06-30: Preferred Stock Dividends, Income Statement Impact $216.00K.
- 2017-03-31: Preferred Stock Dividends, Income Statement Impact $602.00K.
| Period end | Preferred Stock Dividends, Income Statement Impact | Preferred Stock, Dividend Rate, Percentage |
|---|---|---|
| 2017-12-31 | $825.00K 10-K · filed 2020-03-02 | 8.00% 20-F · filed 2018-03-15 |
| 2017-09-30 | $825.00K 6-K · filed 2018-11-13 | |
| 2017-06-30 | $216.00K 6-K · filed 2018-08-14 | |
| 2017-03-31 | $602.00K 6-K · filed 2018-05-15 | |
| 2016-12-31 | $2.47M 10-K · filed 2019-02-28 | |
| 2015-12-31 | $852.00K 20-F · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |